Suzanne Manzi
Physical Medicine & Rehabilitation · Houston, TXNPI 1003051731
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Stimwave Technologies Incorporated at 54.4% of the total. Reporting peaked in 2019 at $51,033 and has fallen 90.1% since, to $5,064 in 2025. Among physical medicine & rehabilitation clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,048 payments — averaging $136.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$78K
- Boston Scientific$10K
- Abbott$9K
- Avanos Medical$7K
- Medtronic$7K
- Eli Lilly$6K
- plus $27K from 54 others
What the payments were for
- Consulting fees$71,35050%
- Speaking & faculty fees$11,9068%
- Travel & lodging$19,12413%
- Food & beverage$36,71126%
- Education$1,0001%
- Gifts$2390%
- Entertainment$2,9662%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCS FreedonSpinal Cord Stimulator$19,824
- StimQ Receiver Stimulator Kit Channel A US w Receiver$19,816
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$19,816
- Freedom 4A Receiver Kit Channel A US w Receiver$19,816
- Freedom 8A Receiver Kit Channel A US w Receiver$19,816
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$17,535
- StimQ Peripheral Nerve StimulatorSystem$17,125
- COOLIEF$6,426
- SPECTRA WAVEWRITER$4,948
- PROCLAIM$4,617
- Nimbus$3,214
- Prospera$3,136
- CFNS StimQ Peripheral Nerve StimulatorSystem$2,699
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$2,507
- Intracept$2,484
- StimQ Freedom 4A Receiver Kit Channel A US Receiver$2,281
- ReActiv8$1,691
- INTELLIS ADAPTIVESTIM$1,175
- WaveWriter Alpha Prime 16$897
- mild Device Kit$885
How this compares
$143,297 in reported general payments places this provider in the 95th percentile of 651 physical medicine & rehabilitation providers in Texas.
See all physical medicine & rehabilitation providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 96 | $82,601 |
| Xtampza ErOxycodone Myristate | 22 | $19,782 |
| MovantikNaloxegol Oxalate | 14 | $9,384 |
| DayvigoLemborexant | 12 | $3,955 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 122 | $3,329 |
| Morphine Sulfate ErMorphine Sulfate | 93 | $3,160 |
| Gabapentin | 99 | $1,858 |
| Pregabalin | 61 | $1,406 |
| Fentanyl | 13 | $1,247 |
| Tramadol Hcl | 62 | $1,035 |
| Methadone Hcl | 47 | $765 |
| Cyclobenzaprine Hcl | 34 | $643 |
| Lidocaine | 11 | $639 |
| Tizanidine Hcl | 35 | $638 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $584 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $811 | $102,383118 claims |
| Redhill Biopharma Inc.Movantik | $232 | $9,38414 claims |
| Eisai Inc.Dayvigo | $108 | $3,95512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 651 physical medicine & rehabilitation providers in Texas.
Other physical medicine & rehabilitation in Houston
- Gerard FranciscoHouston$364K
- Cindy IvanhoeHouston$111K
- Sheng LiHouston$44K
- Purvi DesaiHouston$20K
- Jenny LaiHouston$16K
- Tram PhamHouston$8K
- Marie FrandoHouston$7K
- Bo SongHouston$6K
- Jason HuaHouston$6K
- Teresa KaldisHouston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.